Acarix
0,545 SEK -0,91%1 investor følger denne virksomhed
Acarix is a diagnostics company. The company has developed a technology that enables the identification of coronary heart disease. The company's product is a non-invasive test that is put with a note on the patient to analyze sound from the heart. Operations are mainly conducted in the Nordic market. The company was founded in 2009 as a spin-off from Coloplast. The head office is located in Malmö.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
ACARIX
Daglig lav / høj pris
0,525 / 0,557
SEK
Markedsværdi
563,08 mio. SEK
Aktieomsætning
1,79 mio. SEK
Volumen
3,3 mio.
Finanskalender
Delårsrapport
22.08.2024
Delårsrapport
07.11.2024
Årsrapport
13.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Försäkringsaktiebolaget, Avanza Pension | 6,3 % | 6,3 % |
Mikael Thorén | 3,9 % | 3,9 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Acarix Receives Sizeable Patch Reorder from Louisiana Primary Care Clinic
Acarix receives additional multi unit order from In-Home Concierge Practice
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools